Sun Pharma Agrees to Halt India Sales of Semaglutide After Delhi HC Records Patent Undertaking Susmita Roy11 Dec 2025 4:08 PM ISTNew Delhi: The Delhi High Court on Wednesday recorded a categorical undertaking from Sun Pharma that it will not market or sell its semaglutide...
Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac Susmita Roy10 Dec 2025 5:37 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) recorded a steady rise in November 2025, growing 9.06% month-on-month (MoM) in value, even as unit...
Semaglutide Patent War: After Dr Reddy's Blow, Novo Nordisk Moves Delhi HC Against Sun Pharma Susmita Roy9 Dec 2025 5:00 PM ISTNew Delhi: In an escalation of India's unfolding GLP-1 patent war, Novo Nordisk has approached the Delhi High Court to restrain Sun Pharmaceutical...
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue Susmita Roy5 Dec 2025 10:28 PM ISTNew Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...
Diabetes drugs may help older adults slow frailty, suggests study Dr. Kamal Kant Kohli5 Dec 2025 10:45 AM ISTA new study shows that older adults with type 2 diabetes who start treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors-such as...
Medical Bulletin 04/December/2025 Anshika Mishra4 Dec 2025 3:00 PM ISTHere are the top medical news for today:WHO releases first global guideline on GLP-1 therapies for obesity treatment Obesity now affects over 1...
Semaglutide Helps Counter Antipsychotic-Related Metabolic Risks: JAMA Medha Baranwal4 Dec 2025 11:12 AM ISTDenmark: New research has revealed that low-dose semaglutide significantly improved blood sugar control and reduced weight in patients with...
WHO releases first global guideline on GLP-1 therapies for obesity treatment Anshika Mishra4 Dec 2025 8:00 AM ISTObesity now affects over 1 billion people worldwide, driving millions of deaths and trillions in costs-yet new WHO guidance offers hope through GLP-1...
Novo Nordisk seeks USFDA approval for higher dose of Wegovy injection Ruchika Sharma28 Nov 2025 11:30 AM ISTPlainsboro: Novo Nordisk has announced the submission of a sNDA to the U.S. Food and Drug Administration (FDA) for a higher dose of semaglutide...
Tradipitant may Reduce Semaglutide-Induced Nausea and Vomiting, reports research Dr. Kamal Kant Kohli21 Nov 2025 8:00 PM ISTIn a randomized trial of adults with obesity or overweight, Vanda Pharmaceuticals' investigational NK-1 receptor antagonist tradipitant significantly...
Semaglutide, tirzepatide, and dulaglutide have similar Gl safety profiles in clinical settings, suggests study Dr. Kamal Kant Kohli18 Nov 2025 9:15 AM ISTA new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients...
Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide Dr. Kamal Kant Kohli13 Nov 2025 8:15 PM ISTInjectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical...
